SYNTHESIS AND EVALUATION OF HYBRID HETEROCYCLES





The thesis entitled “Synthesis and evaluation of hybrid heterocycles as novel 
antitubercular agents and total synthesis of Enigmol” has been divided into four Chapters. 
 
Chapter I : Design, synthesis and evaluation of novel dihydroquinoline 
derivatives as inhibitors of Mycobacterium tuberculosis. 
Chapter II : Synthesis and antitubercular evaluation of novel dibenzo[b,d] 
thiophene-1,2,3-triazoles appended with cyclic and acyclic 
amines. 
Chapter III : This chapter is subdivided into two sections.     
Section A : Synthesis and antitubercular evaluation of novel dibenzo[b,d] 
thiophene tethered imidazo[1,2-a]pyridine-3-carboxamides. 
Section B : Synthesis and evaluation of substituted thiazole/benzothiazole 
coupled (E)-dibenzo[b,d]thiophene-2-yl acrylamides as potent  
inhibitors of Mycobacterium tuberculosis. 
Chapter IV : Total synthesis of Enigmol 
   






 Chapter I  : Design, Synthesis and evaluation of novel dihydroquinolino 
derivatives as inhibitors of Mycobacterium Tuberculosis.  
INTRODUCTION: 
Tuberculosis: 
Tuberculosis (TB) is an ancient, contagious disease caused by pathogen called 
Mycobacterium tuberculosis. The TB bacteria usually affect the lungs. The resurgence of 
tuberculosis (TB) is one of the most serious public health concerns worldwide. The 
causative pathogen Mycobacterium tuberculosis (Mtb) is observed more frequently in 
immune-compromised individuals suffering from human immune deficiency virus (HIV). 
According to World Health Organization (WHO) global tuberculosis report 2015, TB 
killed 890,000 men, 480,000 women and 140,000 children in 2014 alone, and the disease 
ranked alongside HIV as a leading killer worldwide.
 
The current situation necessitates 
examination of various old drug families for developing new antimycobacterial entities 
with novel mechanism of action to achieve effective TB control even against the resistant 
forms of TB. It has been also noticed that more than 50 years elapsed, there is no single 
drug developed for the treatment of TB. The worsening situation has prompted WHO to 
declare tuberculosis as a global public health crisis. 
In recent time drug-resistant tuberculosis was emerged as a major clinical and public 
health challenge in the forms of multidrug-resistant tuberculosis (MDR-TB) and 
extensively drug resistant TB (XDR-TB). Multidrug-resistant (MDR) tuberculosis is 
defined as disease caused by strains of Mycobacterium tuberculosis that are resistant to 
treatment with isoniazid and rifampicin. Extensively drug-resistant (XDR) tuberculosis 
refers to disease caused by multidrug-resistant strains that are also resistant to treatment 
with any fluoroquinolone and any of the injectable drugs used in treatment with second-
line anti-tuberculosis drugs. 
The standard short course for the treatment of TB utilizes standard first line drugs 
(Figure 1) such as Isoniazid (along with pyridoxal phosphate to obviate peripheral 
neuropathy caused by Isoniazid), Rifampicin, Pyrazinamide and Ethambutol for two 
months, then Isoniazid and Rifampicin alone for a further four months. The reason for the 
long term treatment is that, it is very difficult to entirely eliminate the causative pathogen, 








Quinoline and their derivatives are an important class of aza-heterocycles found in 
many natural products and active pharmaceuticals. Several quinoline containing 
compounds exhibit a wide spectrum of pharmacological activities, such as antimalarial, 
antiplasmodial, cytotoxic, antibacterial, antiproliferative, antituberculosis and anticancer 
activity. The quinoline skeleton is often used for the design of many synthetic compounds 
with diverse pharmacological properties. 
 
Figure 2 
In recent years quinoline derivatives fused and/or substituted with heterocyclic rings 
were demonstrated to have significant biological activities. In perticular antimicrobial and 
antituberculosis activity was found in heterocycles 10 & 11 where in oxazole and 
isoxazole
 
ring in the quinoline core. Pyrazole containing pharmacoactive agents play 










As a part of our ongoing investigations in the discovery of new antitubercular 
compounds and the importance of quinoline derivatives in medicinal chemistry, we 
envisioned to synthesize new fused heterocyclic dihydroquinolines. To begin with, 




Synthesis of Hydroxy acetyl dihydroquinolines: 
 
Scheme 2 
With the desired quinolinone building block 16a in hand, various reaction conditions 
were screened to effect the desired hydroxy acetyl quinolines (Table 1). Initial efforts 





methane unsuccessful for the acylation of quinolinone 16a. Acylation of 16a was 
successful using NaH in ethyl acetate gave the product 17a in 15% yield. Finally, 
acylation preceded smoothly using sodium hydride in ethyl acetate at 80 °C to give the 
desired product 17a in 80% yield.  
Table 1: Optimization of reaction conditions for the acylation of quinolinone 16a 
     
a
All the reactions were performed with 16a (1.0 mmol) & solvent (5 mL) 
  
Reaction of various dihydro-6H-quinolin-5-ones (16a-k) with sodium hydride and 
ethyl acetate at 80 
o
C for 1.5 h resulted hydroxyl acetyl dihydroquinolines (17a-k) in 
good yield (Scheme 3).  The crude isomeric mixture of 17a-k was separated over silica 
gel column chromatography. All the products thus obtained were fully characterized by 





H-NMR spectrum of 17e revealed aromatic protons at δ 8.21 (1H) as doublet    
(J = 8.0 Hz), at δ 7.69 (1H) as doublet (J = 8.0 Hz), δ 7.65-7.58 (1H) as multiplet, δ 7.39 
(1H) as triplet (J = 7.9 Hz), δ 7.02-6.97 (1H). The methoxy (-OCH3) protons appeared at 
δ 3.90 (3H) as singlet, the methylene (-CH2) protons appeared at δ 3.15 (2H) as triplet     
(J = 7.6 Hz) and at δ 2.77 (2H) as triplet (J = 7.6 Hz) and the characteristic methyl 
S.No Reagent Solvent Temperature Time Yield (%) 
1 BF3-etherate AC2O 0 
o






C to RT 24 h -- 
3 NaH EtOAc RT 24 h 15 
4 NaH EtOAc 80 
o





protons (-CH3) appeared at δ 2.27 (3H) as singlet. In HR-MS (ESI) spectrum the peak 
observed at m/z 296.12753 for C18H18NO3 [M+H]
+
 confirmed the structure 17e as 1-(5-
hydroxy-2-(3-methoxyphenyl)-7,8-dihydroquinolin-6-yl)ethanone.  
Synthesis of dihydroquinoline derivatives from hydroxy acetyl dihydroquinolines 
17a-k: 
With the required Hydroxy acetyl dihyroquinolines 17a-k in hand, we have performed 
a reactions involving with hydroxylamine, hydrazine hydrate and 3-aminopyrazole in 
methanol at 80 
o
C for 12 h gave dihydroisoxazoloquinolines 18a-k, dihydropyrazolo 
quinolines 19a-k and dihydropyrazolopyridoquinazolines 20a-k respectively in good 
yields (Scheme 4).  
 
Scheme 4 
The compound 18g was characterized from the 
1
H-NMR spectrum by the appearance 
of aromatic protons at δ 8.11 (2H) as doublet (J = 9.0 Hz), δ 7.94 (1H) as doublet (J = 8.3 
Hz), δ 7.77-7.62 (5H) as multiplet, δ 7.48 (2H) as triplet (J = 8.3 Hz), δ 7.43-7.33 (1H) as 
multiplet. The methylene (-CH2) protons appeared at δ 3.33 (2H) as triplet (J = 8.3 Hz) 
and at δ 2.83 (2H) as triplet (J = 8.3 Hz), methyl protons (-CH3) appeared at δ 2.33 (3H) 
as singlet. In HR-MS (ESI) spectrum the peak observed at m/z 313.13322 for C23H19N2O 
[M+H]
+
 confirmed the structure 18g as 7-([1,1'-biphenyl]-4-yl)-3-methyl-4,5-dihydro 





NMR, IR and Mass spectral analysis.  
The structure of the compound 18g and its regioselectivity was unambiguously 






Figure 4: ORTEP diagram of compound 18g 
The compound 19g was characterized from the 
1
H-NMR spectrum by the appearance 
of aromatic protons at δ 8.21 (1H) as doublet (J = 8.3 Hz), δ 8.08-7.86 (2H) as multiplet, 
δ 7.84-7.71 (4H) as multiplet, δ 7.50 (2H) as triplet (J = 7.1 Hz), δ 7.44-7.36 (1H) as 
multiplet. The methylene (-CH2) protons appeared at δ 3.12 (2H) as triplet (J = 7.5 Hz) 
and at δ 2.78 (2H) as triplet (J = 7.5 Hz) and methyl protons (-CH3) appeared at δ 2.22 
(3H) as singlet. In HR-MS (ESI) spectrum the peak observed at m/z 338.16579 for 
C23H20N3 [M+H]
+
 confirmed the structure 19g as 7-(biphenyl-4-yl)-3-methyl-4,5-dihydro-





NMR, IR and Mass spectral analysis.  
The structure of the compound 19g and its regioselectivity was unambiguously 
confirmed by its single crystal X-ray analysis (Figure 5). 
 
Figure 5: ORTEP diagram of compound 19g 
The compound 20k was characterized from the 
1
H-NMR spectrum by the appearance 
of aromatic protons at δ 9.68 (1H) as doublet (J = 8.5 Hz), δ 8.12 (1H) as doublet (J = 2.2 
Hz), δ 7.71-7.66 (2H), 7.45 (1H) as doublet  of doublet (J = 5.0, 0.9 Hz) , δ 7.14 (1H) as 
doublet of doublet (J = 5.0, 3.6 Hz), δ 6.64 (1H) as doublet (J = 2.2 Hz). The methylene  
(-CH2) protons appeared at δ 3.25-3.20 (2H) and at δ 3.07-3.02 (2H), methyl protons           
(-CH3) appeared at δ 2.65 (3H) as singlet. In HR-MS (ESI) spectrum the peak observed at 
m/z 319.10123 for C18H15N4S [M+H]
+





(thiophen-2-yl)-6,7-dihydropyrazolo [1,5-a]pyrido[2,3-h]quinazoline. All the derivatives 




C NMR, IR and Mass spectral analysis. 
The structure of the compound 20i and its regioselectivity was unambiguously 
confirmed by its single crystal X-ray analysis (Figure 6). 
 
 Figure 6: ORTEP diagram of compound 20i. 
Pharmacology: 
The antitubercular activity of all the synthesized compounds 18a-k, 19a-k & 20a-k 
screened have showed in vitro activity against Mycobacterium tuberculosis H37Rv with 
MIC values ranging from 0.40-25 µg/mL. Among them, one compound 20h with MIC 
0.40 µg/mL, three compounds 18e, 18i and 19i with MIC 1.56 µg/mL and five 
compounds 18d, 19b, 19j, 20b and 20k with MIC 3.13 µg/mL. The in vitro cytotoxicity 
evaluation of all compounds revealed that compounds 18e, 18i, 19i and 20h exhibited 
26.5%, 42.1%, 19.5% and 21.5% inhibition at 50 μg/mL. 
CONCLUSION: 
In conclusion we have synthesized a new class of dihydroisoxazoloquinolines           
18a-k, dihydropyrazoloquinolines 19a-k and dihydropyrazolopyridoquinazolines 20a-k. 
Screening all these new analogues against Mtb resulted one compound 20h                        
(MIC 0.40 µg/mL) as most potent antitubercular agent with low cytotoxicity. 
Chapter II : Synthesis and antitubercular evaluation of novel dibenzo 




Dibenzothiophene 21 is a tricyclic organosulfur compound consisting of two benzene 
rings fused to a central thiophene ring. It is occurring widely in heavier fractions of 





Graebe contributed a lot in understanding the regioselectivity and other properties of 
dibenzothiophene. 
 
Synthetic bioactive analogues of dibenzothiophene: 
Cano et al., synthesized DNA-dependent Protein Kinase (DNA-PK) Inhibitors of 
dibenzo thiophene containing Quinolin-4-one and Pyridopyrimidin-4-one surrogates for 
the chromen-4-one. Curtin et al., described chemosensitisation of cancer cells, dual 




The basic heterocyclic rings present in the various medicinal agents are mainly 1,2,3- 
triazole and 1,2,4-triazole. A large volume of research has been carried out on triazole 
and their derivatives exhibiting wide range of biological activities, such as anticancer, 
antitubercular, antifungal, anticonvulsant, antibacterial and HIV protease inhibitors. 
There are very few 1,2,3-triazole containing molecules on the market or are in the last 
stage of clinical trials. Potential pharmaceuticals based on 1,2,3-triazoles include the 
anticancer compound Carboxyamidotriazole (CAI), the nucleoside derivative non-
nucloside reverse transcriptase inhibitor tert-Butyldimethylsilylspiroaminooxathiole 






 Figure 8 
PRESENT WORK: 
Earlier work from our group on development of novel bioactives resulted dibenzo[b,d]furan, 
dibenzo[b,d]thiophene and N-methyl carbazole tethered substituted 1,2,3-triazoles with potent 
antimycobacterial activity. Structure-activity relationships (SAR) revealed that dibenzo[b,d] 
thiophene tethered 1,2,3-triazoles exhibited M. tuberculosis inhibition at lower 




These observations led us to focus on development of dibenzo[b,d]thiophene derived 
newer scaffolds to screen their antitubercular activity. In clinical antitubercular agents 
pharmacophoric morpholine, thiomorpholine, piperidine or piperazine units play vital role 
in the inhibition of M. tuberculosis.
 
Continuing our efforts on the development of newer 
and potent antitubercular agents, we envisaged that, maneuvering dibenzo[b,d]thiophene-
1,2,3-triazoles appended with morpholine, thiomorpholine, piperidine, piperazine, 
pyrrolidine and 2-adamantane amine in single molecular frame could deliver new 





for synthesis of 1,2,3-triazole conjugates was based on Huisgen 1,3-dipolar cycloaddition 
reaction (click reaction) of alkynes and azides. 
A more holistic approach for design strategy would be through, i) correlation of the 
structural features of widely used drugs; ii) identification of common pharmacophoric 
unit(s) and iii) incorporate them to generate newer scaffolds with envisaged activity 
profile. With the fact that piperidine, piperazine, morpholine, thiomorpholine, pyrrolidine 
and 2-adamantane amine are prominent in TB drugs, a design strategy is formulated to 
inculcate these units into the dibenzo[b,d]thiophene-1,2,3-triazole architecture (Figure 9). 
 
Scheme 5 
Compound 30 was prepared by acylation of dibenzo[b,d]thiophene 21, was alpha 
brominated with NH4Br and oxone gave 31, coupled to various cyclic and acyclic amines 
32a-g gave 33a-g, reduced to alcohol derivatives 34a-g using NaBH4. The azide building 
blocks 35a-g were accomplished in excellent yields (85-92%) from alcohols 34a-g with 
DPPA, DBU in THF at 0 °C to RT for 12 h. Boc deprotection of 35d with methanolic 
HCl gave 35h and TBS deprotection of 35e with TBAF gave 35i. 
With the required azides in hand, the 1,3-dipolar cycloaddition reactions of azides 





using copper sulfate and sodium ascorbate at room temperature in aqueous tert-butanol 
for 12 h gave 4-(2-(dibenzo[b,d]thiophen-2-yl)-2-(4-p-tolyl-1H-1,2,3-triazol-1-yl)ethyl) 
thiomorpholine (39b) in 84% yield (Scheme 6).  
 
Scheme 6 
Table: Synthesis of 1,2,3-triazole derivatives using click chemistry 










































The triazole derivative 39c was characterized from 
1
H NMR spectrum by the 
appearance of aromatic protons at δ 8.18-8.10 (2H) as multiplet, at δ 7.89-7.82 (2H) as 
multiplet, at δ 7.78 (1H) as singlet, at δ 7.76-7.68 (2H) as multiplet, at δ 7.52-7.41 (3H) as 
multiplet, at δ 7.22 (2H) as doublet (J = 7.9 Hz). The benzylic proton (Ar-CH) appeared 
at δ 5.90 (1H) as doublet of doublet (J = 8.6, 5.4 Hz), methylene protons (-CH2) at δ 3.65 
(1H) as doublet of doublet (J = 13.7, 8.6 Hz) and δ 3.24 (1H) as doublet of doublet (J = 
13.7, 5.4 Hz), thiomorpholine protons at δ 2.96-2.75 (4H) as multiplet (N-attached) and δ 
2.57 (4H) as triplet (J = 4.9 Hz) (S-attached), methyl protons (-CH3) at δ 2.37 (3H) as 
singlet. In HR-MS (ESI) spectrum the peak observed at m/z 471.16585 for C27H27N4S2 
(M+H)
+




A total of ‘42’ newly synthesized dibenzo[b,d]thiophene-1,2,3-triazole analogues 
were screened for antimycobacterial activity and have showed in vitro activity against 
Mtb with MICs ranging from 0.78-50.0 µg/mL. Among them, two compounds 37a & 37f 
inhibited Mtb with MIC 0.78 µg/mL. The in vitro cytotoxicity evaluation of all 
compounds 37a-f, 38a-f, 39a-f, 40a-f, 41a-f 42a-f & 43a-f revealed that compounds 37a 
and 37f exhibited 25.4% and 20.6% inhibition at 50μg/mL. 
CONCLUSION: 
In conclusion, we synthesized a series of new dibenzo[b,d]thiophene clubbed-1,2,3-
triazole appended with  cyclic and acyclic amines. Screening all the compounds for in 
vitro antimycobacterial activity against Mycobacterium tuberculosis H37Rv resulted, 
almost all the derivatives were more potent than standard drugs. Among all the 
compounds screened, 37a and 37f possess the maximum Mtb inhibitory activity with 







& Section A 
: Synthesis and antitubercular evaluation of novel dibenzo 
[b,d]thiophene tethered imidazo[1,2-a]pyridine-3-carboxamides. 
INTRODUCTION: 
Imidazopyridine, the imidazole moiety fused with the pyridine ring, is an important 
biologically active nitrogen containing heterocycle. Among the various imidazopyridine 
derivatives, the imidazo[1,2-a]pyridine moiety is the most important in the area of natural 
products and pharmaceuticals. 
 
Figure 10 
As a result of our interest in the synthesis of imidazopyridine-containing compounds 
and their antimicrobial activity, we initiated a program directed towards the synthesis of 
the new imidazopyridine amide derivatives. Imidazopyridine amides (IPA) are a new 
class of therapeutic agents against MDR and XDR tuberculosis. Recently, Qurient 
therapeutics discovered 45: Q-203 (Figure 10), a highly innovative drug for MDR and 
XDR tuberculosis and the first drug in its class with an original mechanism of action. 
PRESENT WORK:  
  
Figure 11 
Inspired by the applications of dibenzo[b,d]thiophene derivatives in the field of 
medicinal chemistry, especially in treatment of tuberculosis. Since imidazopyridine 
constitutes an important class of heterocyclic compound possessing diverse 
pharmacological activities, we decided to develop a novel dibenzothiophene tethered 





The designed scaffold was broadly divided into three segments (Figure 11). First 
segment is imidazo[1,2-a]pyridine, an active pharmacophore from clinical antitubercular 
TB drug Q-203. Bioactive dibenzo[b,d]thiophene is the second segment tethered to 
imidazo[1,2-a]pyridine core for desired pharmacological behavior. Anti-TB activity 
profile of the proposed scaffold was tuned with the choice of appended substituted benzyl 
amines in the third segment. 
 
Scheme 7 
The required building block, 2-dibenzo[b,d]thiophenyl imidazo[1,2-a]pyridine 
carboxylic acid 49 was synthesized from commercial dibenzo[b,d]thiophene.                            
1-(dibenzo[b,d]thiophen-2-yl)ethanone 30 prepared in chapter-II was used as starting 
material. Reaction of 1-(dibenzo[b,d]thiophen-2-yl)ethanone 30 with sodium hydride in 
diethyl carbonate at 130 
o
C for 1.5 h afforded ethyl 3-(dibenzo[b,d]thiophen-2-yl)-3-
oxopropanoate 46, which was α-brominated  with ammonium bromide and Oxone in 
methanol at 80 
o
C for 1.5 h afforded ethyl 2-bromo-3-(dibenzo[b,d]thiophen-2-yl)-3-
oxopropanoate 47. Ethyl 2-bromo-3-(dibenzo[b,d]thiophen-2-yl)-3-oxo propanoate 47 
was reacted with 2-amino pyridine at 55 
o
C for 6 h afforded ethyl 2-(dibenzo[b,d] 
thiophen-2-yl)imidazo[1,2-a]pyridine-3-carboxylate 48. Ethyl 2-(dibenzo[b,d]thiophen-2-
yl)imidazo[1,2-a]pyridine-3-carboxylate 48 saponification with lithium hydroxide 
followed by acidic work up gave the desired 2-(dibenzo[b,d]thiophen-2-yl)imidazo[1,2-a] 
pyridine-3-carboxylic acid 49 in 70% overall yield as white solid (Scheme 7).  
Further to build the desired amide analogues, 2-(dibenzo[b,d]thiophen-2-yl)imidazo    
[1,2-a]pyridine-3-carboxylic acid 49 was coupled with various benzyl amines 50a-s using 
classical EDCI-HOBT protocol (Scheme 8). For example, compound 49 was reacted with 












The carboxamide derivative 51d was characterized from 
1
H-NMR spectrum by the 
appearance of aromatic proton at δ 9.52 (1H) as doublet (J = 6.9 Hz), δ 8.40 (1H) as 
doublet (J = 1.1 Hz), δ 8.09-8.02 (1H) as multiplet, δ 7.92-7.86 (1H) as multiplet, δ 7.79 
(1H) as doublet (J = 8.3 Hz), δ 7.69-7.62 (2H) as multiplet, δ 7.55-7.43 (2H) as multiplet, 
δ 7.41-7.33 (1H) as multiplet, δ 7.01-6.82 (5H) as multiplet and amide proton (-NH) 
appeared at δ 6.21 (1H) as triplet (J = 4.9 Hz), benzylic protons (-CH2) appeared at δ 4.41 
(2H) as doublet (J = 5.4 Hz) and methyl protons (-CH3) appeared at δ 2.21 (3H) as 
singlet. In HR-MS (ESI) spectrum the peak observed at m/z 448.14664 for C28H22N3OS 
[M+H]
+ 
confirmed the structure 51d as 2-(dibenzo[b,d]thiophen-2-yl)-N-(4-methyl 
benzyl)imidazo[1,2-a]pyridine-3-carboxamide. 
Antitubercular evaluation: 
The in vitro antitubercular evaluation of all the synthesized 51a-s against 
Mycobacterium tuberculosis H37Rv (Mtb) showed MIC values ranging from 0.78–50.0 





compounds 51e & 51n inhibited Mtb with MIC 1.56 µg/mL. The in vitro cytotoxicity 
evaluation of all compounds 51a-s revealed that compounds 51k, 51e and 51n exhibited 
34.7%, 18.7% and 24.3% inhibition at 50μg/mL. 
CONCLUSION: 
In conclusion, we have synthesized a series of novel dibenzo[b,d]thiophene tethered 
imidazo[1,2-a]pyridine-3-carboxamides 51a-s. Screening all these new derivatives 51a-s 
against M. tuberculosis H37Rv (Mtb) resulted three compounds 51e, 51k and 51n are 
active antitubercular agents with lower cytotoxicity profile and among these three, 51k is 
the most active (MIC 0.78 µg/mL) and least cytotoxic compound. 
 
Chapter III 
& Section B 
: Synthesis and evaluation of substituted thiazole/benzothiazole 
coupled (E)-dibenzo[b,d]thiophene-2-yl acrylamides as potent  
inhibitors of Mycobacterium tuberculosis 
INTRODUCTION: 
Cinnamic acid is a component of plant-derived scents and flavourings. It belongs to 
the class of auxin, which is recognized as plant hormones regulating cell growth and 
differentiation. Cinnamic acid 52 and its derivatives have a century-old history as 
antituberculosis agents. For example, gradual improvement was observed when the TB-
patients were treated with cinnamic acid and ethylcinnamate 53. The hydroxyl cinnamic 
acids such as p-coumaric acid 54, caffeic acid 55, ferulic acid 56, sinapic acid 57 are 
natural products arising from the deamination of the phenyl alanine. 
 
Figure 12 
Thiazoles are one of the most intensively investigated classes of aromatic five-
membered heterocycles. These are found in many potent biologically active molecules 
and show a various pharmacological application. Several natural and synthetic thiazole 





many potent biologically active molecules such as Sulfathiazole 58 as antibacterial drug, 





To begin with, dibenzo[b,d]thiophene-2-caraboxaldehyde 64, required was prepared 
according to the literature procedure. (E)-3-(dibenzo[b,d]thiophen-2-yl)acrylicacid 65 
required was prepared from dibenzo[b,d]thiophene-2-caraboxaldehyde 64. Initially 
aldehyde 64 was reacted with malonic acid in presence of piperidine in pyridine solvent at 
90 
o





The required cinnamide derivatives were synthesized by coupling of (E)-3-
(dibenzo[b,d] thiophen-2-yl)acrylicacid 65 with different substituted 2-amino thiazoles 
and 2-amino benzothiazoles 66a-i. Firstly, the (E)-3-(dibenzo[b,d]thiophen-2-yl)acrylic 
acid converted into (E)-3-(dibenzo[b,d]thiophen-2-yl)acryloyl chloride with thionyl 
chloride at 65 
o
C for 3 h, then coupling with 66a-i in presence of triethylamine in 












C NMR, IR 
and mass spectral data.  
The compound 67d was characterized from 
1
H NMR spectrum by the appearance of 
amide proton at δ 12.26 (1H) as broad singlet, aromatic protons at δ 8.46 (1H) as singlet, 
δ 8.328-8.29 (1H) and δ 8.03-7.85 (3H) as multiplet, δ 7.75 (1H) as doublet (J = 8.2 Hz), 
δ 7.568-7.48 (2H) as multiplet. The characteristic trans olefin proton appeared at δ 7.06 
(1H) as doublet (J = 15.6 Hz), thiazole proton at δ 6.63 (1H) as singlet and tert butyl 
protons at (-C(CH3)3) at δ 1.31 (9H) as singlet. In HR-MS (ESI) spectrum the peak 
observed at m/z 393 for C22H21N2OS2 [M+H]
+
 confirmed the structure 67d as (E)-N-(4-
tert-butylthiazol-2-yl)-3-(dibenzo[b,d]thiophen-2-yl)acrylamide. 
The structure of the compound 67d was unambiguously confirmed by its single 
crystal X-ray analysis (Figure 14) 
                            








All the new compounds were screened showed in vitro activity against Mtb with MIC 
ranging from 3.13-25 µg/mL. Among them, one compound 67a inhibited Mtb with MIC 
of 3.13 µg/mL, another compound 67h inhibited Mtb with MIC 6.25 µg/mL. The in vitro 
cytotoxicity evaluation of all compounds 67a-i revealed that compounds 67a and 67h 
exhibited 12.5% and 40.6% inhibition at 50 μg/mL. 
CONCLUSION: 
 In conclusion, we have synthesized a novel series of dibenzo[b,d]thiophene tethered 
cinnamides 67a-i. Screening all these new derivatives against Mtb revealed that 67a is 
active antitubercular agent. 
Chapter IV  : Total synthesis of Enigmol 
Introduction: 
Sphingolipids are composed of a structurally related family of backbones termed 
sphingoid bases, which are sometimes referred to as “long-chain bases” or 
“sphingosines.” Sphingolipids are a class of lipids derived from the aliphatic amino 
alcohol sphingosine. Sphingolipids are often found in neural tissues, and play an 
important role in both signal transmission and cell recognition.
2
 This diverse family of 
biomolecules is structurally characterized by a long carbon chain ‘sphingoid’ base that is 
derivatized with amide linked fatty acids and various polar head groups. 
 
Figure 15 
The 1,2-amino alcohol moiety is present in sphingolipids, and recently, the 1-deoxy-
5-hydroxy sphingosine analogues have been identified as a potential new class of 
anticancer principles (Figure 15), Enigmol inhibits both sphingosine kinase and ceramide 
synthase  in vitro, and  it has demonstrated potent anticancer activity in cells derived from 
multiple types of cancer, including colon, breast, brain, and prostate. Due to potential 







Synthesis of Enigmol 56:  
We planned to synthesize Enigmol 68 from commercially available D-glucose. D-glucose  
was considered as the suitable precursor for the preparation of 68. Retrosynthetic analysis 
for compound 68 is presented in Scheme 11. 
 
Scheme 11 
The key steps are (i) Formation of epoxide in C1-C2 (ii) Regioselective opening of 
epoxide (iii) Wittig olefination of lactol (iv) Grubbs reaction between synthesized alkene 
and 1-tridecene. Finally, reduction leads to the desired Enigmol 68. Thus, retro 
synthetically enigmol could be derived from D-glucose. 
 
Scheme 12 
   D-glucose was transformed to diacetonide 75 by reaction with anhydrous CuSO4, 
cat. H2SO4 in acetone for 24 h in 85.6% yield. Formation of diacetonide 75 was evident 
from characteristic 
1
H NMR spectrum by the appearance of methyl protons at δ 1.50 





converted into xanthate derivative followed by deoxygenation under the Barton–
McCombie protocol using n-Bu3SnH and a catalytic amount of AIBN in toluene under 
reflux conditions to provide the 3-deoxyglucose derivative 74 in 85.6% yield over two 
steps. Formation of deoxy glucose evident from 
1
H NMR spectrum by the appearance of 
protons at δ 2.19 (1H) as doublet of doublet (J = 13.4, 4.1 Hz) and at δ 1.81-1.73 (1H) as 
multiplet. Selective deprotection of 74 with 0.3N H2SO4 in MeOH for 6 h leads to diol 76 
as syrup in 94% yield (Scheme 11). Formation of diol 76 was evident from 
1
H NMR 
spectrum by the disappearance of C-5, 6-acetonide protons at δ 1.43 (3H), 1.36 (3H) and 
appearance of hydroxyl absorptions at 3416 cm
-1
. Epoxidation of 76 with 
triphenylphosphine and diisopropylazodicarboxylate (DIAD) in toluene afforded epoxide 
73 in 84.7% yield. Formation of epoxide 73 was evident from IR spectrum by the 





Regioselective opening of epoxide 73 with LiAlH4 at 0 
o
C to RT for 12 h gave 77 in 
96.3% yield. Formation of 77 was evident from 
1
H spectrum by the appearance of methyl 
proton at δ 2.19 (3H) as doublet (J = 5.9 Hz) and appearance of hydroxyl absorptions at 
3452 cm
-1
. The hydroxy group in compound 77 was treated with triphenylphosphine, 
DIAD and diphenyl phosphoryl azide (DPPA) at 0 
o
C to RT for 12 h gave azido 
compound 72 as syrup in 71.2% yield. Formation of azide 72 was evident from IR 
spectrum by the appearance azide absorptions at 2171 cm
-1
. Deprotection of 1,2-O-
isopropylidene group of compound 72 with 1,4-dioxane and 3.2 M aq HCl (1:1) at 0 
o
C to 
RT for 12 h afforded the lactol 78 as a solid in 90.2% yield (m.p. 53-55 
o
C). Formation of 
lactol 78 was evident from the 
1
H NMR spectrum by the disappearance of 1,2-acetonide 









The relative stereochemistry of the C-3 and C-5 1,3-diols was confirmed by using 
Rychnovsky’s acetonide methodology with 
13
C NMR analysis. Protection of the 1,3-syn 
diol 71 with 2,2-DMP and CSA (cat.) in CH2Cl2 at 0 
o
C to RT for 12 h gave acetonide 79 
as colorless oil in 92% yield (Scheme 14). Analysis of the 
13
C NMR chemical shifts at δ 
19.6, 32.9 and 98.9 for 79, confirmed the 1-3-syn relationship. 
 
Scheme 15 
Compound 70 was achieved from synthesized alkene 71 with 1-tridecene 80 using 
Grubbs-II generation catalyst in CH2Cl2 at reflux temperature for 48 h gave 70 as 
colorless oil in 42.1% yield. Formation of 70 was characterized from 
1
H NMR spectrum 
by the appearance of olefinic protons at δ 5.73-5.65 (1H) as multiplet, 5.52-5.45 (1H) as 
multiplet and methylene protons at δ 1.40-1.24 (21 H) as multiplet. 
 
Scheme 16 
Reduction of 70 with Palladium hydroxide on carbon under hydrogen atmosphere in 
ethanol at RT for 12 h afforded Enigmol 68 as white solid (m.p. 68-70 
o
C) in 47.8% yield. 
Spectral and analytical data obtained for 68 was consistent with those reported in the 
literature.
 
In conclusion, we have completed the total synthesis of the biologically active 
natural product Enigmol starting from D-glucose.  
CONCLUSION: 
 In conclusion, an elegant approach to the synthesis of Enigmol 68 in 3.93% overall 
yield from D-glucose.  
